FDA Issues Alert for Counterfeit Botox Across Multiple U.S. States
The U.S. Food and Drug Administration on Tuesday alerted health care professionals and consumers that unsafe counterfeit versions of AbbVie’s Botox were given to consumers for cosmetic purposes in multiple states.
The U.S. Centers for Disease Control and Prevention (CDC) and the FDA are investigating reports of harmful reactions among people who received injections of counterfeit Botox.
As of April 12, a total of 19 people from nine states had reported harmful reactions after receiving Botox injections from unlicensed or untrained individuals, or in non-healthcare settings, such as homes and spas, according to the CDC.
Read more at Reuters >>
View the alert at U.S. Food & Drug Administration >>
